Healthpeak Properties (DOC) AI Stock Analysis

• Market Cap: $12.99B
• Dividend Yield: 6.78%
• Average Volume (3M): 6.07M
• Price to Earnings (P/E): 44.8
• Beta (1Y): 0.65
• Revenue Growth: 23.65%
• EPS Growth: 12.82%
• Country: US
• Employees: 387
• Sector: Real Estate
• Sector Strength: 80
• Industry: REIT - Healthcare Facilities
• EPS (TTM): 0.40
• Shares Outstanding: 714,732,100
• 10 Day Avg. Volume: 6,221,623
• 30 Day Avg. Volume: 6,072,035
• PEG Ratio: 3.50
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 1.83
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: 14.68
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $23.50
• Price Target Upside: 31.95% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 10

Healthpeak Properties exhibits strong financial performance, particularly in revenue growth and cash flow management. However, high leverage and bearish technical indicators pose significant risks. While the earnings call highlights strategic successes, the challenges in the Lab segment are concerning. The recent corporate events show positive leadership changes and strategic initiatives, but the high P/E ratio raises valuation concerns. The attractive dividend yield partially offsets these risks, appealing to income-focused investors.

Positive Factors

Partnerships and Collaborations

DOC announced a new partnership with Hines, indicating potential growth and collaboration opportunities.

Share Buybacks

The company repurchased $94 million in shares, signaling confidence in its own stock value.

Negative Factors

Financial Guidance

FY25 Adj-FFO guidance was maintained at $1.84/sh, below Street/BMO's $1.85.

Market Challenges

The transition from distressed lab investments to share buybacks highlights a challenging macro environment for VC funding and lab leasing.

Healthpeak Properties Business Overview & Revenue Model

Company Description

Healthpeak Properties, Inc. is a leading real estate investment trust (REIT) specializing in the ownership, development, and management of healthcare real estate. The company's portfolio primarily focuses on life science campuses, medical offices, and senior housing properties. Healthpeak's strategic investments are aimed at meeting the evolving needs of the healthcare industry and enhancing the quality of healthcare delivery across the United States.

How the Company Makes Money

Healthpeak Properties generates revenue primarily through leasing its real estate assets to tenants in the healthcare sector. The company's key revenue streams include rental income from its life science buildings, medical office buildings, and senior housing properties. Additionally, Healthpeak benefits from property management fees and development services. The company's earnings are bolstered by long-term leases with healthcare providers, research institutions, and senior housing operators, which provide a stable and predictable cash flow. Strategic partnerships and acquisitions also contribute to revenue growth, enabling Healthpeak to expand its portfolio and enhance its market presence in the healthcare real estate sector.

Healthpeak Properties Financial Statement Overview

Summary

Healthpeak Properties demonstrates solid financial health with strong revenue growth and efficient cash flow management. Despite improving profitability metrics, high leverage is a potential risk that requires monitoring. Overall, the company is well-positioned in its industry with opportunities for further operational enhancements.

Income Statement

Healthpeak Properties shows a strong revenue growth trajectory with a significant increase from 2024 to TTM (Trailing-Twelve-Months). The gross profit margin remains healthy, indicating good control over cost of sales. While net profit margin shows improvement over time, there is room for optimization in operational efficiency to enhance profitability further.

Balance Sheet

The company's debt-to-equity ratio is relatively high, indicating leveraged operations. However, the return on equity is decent, highlighting effective use of shareholder equity. The equity ratio is stable, suggesting a balanced approach to asset management, but high debt levels could pose future risks.

Cash Flow

Operating cash flow is robust with consistent free cash flow growth, signaling strong cash generation capabilities. The operating cash flow to net income ratio is favorable, demonstrating efficient cash conversion. However, attention to investing and financing activities is recommended to maintain liquidity.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
2.70B	2.18B	526.63M	457.70M	437.50M
	Gross Profit
1.62B	1.28B	355.54M	320.29M	309.31M
	EBIT
471.22M	1.18B	124.89M	123.09M	124.70M
	EBITDA
1.61B	1.19B	314.54M	280.96M	1.13B
	Net Income Common Stockholders
243.14M	306.01M	37.80M	25.40M	10.20M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
119.82M	138.99M	7.73M	9.88M	2.52M
	Total Assets
19.94B	15.70B	5.10B	5.18B	4.41B
	Total Debt
9.02B	7.08B	1.92B	2.02B	1.51B
	Net Debt
8.90B	6.97B	1.92B	2.01B	1.51B
	Total Liabilities
10.88B	8.77B	2.10B	2.19B	1.67B
	Stockholders Equity
8.40B	6.35B	2.87B	2.84B	2.64B
Cash Flow		Free Cash Flow
1.07B	956.24M	218.53M	214.99M	199.41M
	Operating Cash Flow
1.07B	956.24M	258.40M	247.56M	233.30M
	Investing Cash Flow
-113.80M	-576.75M	-38.47M	-603.22M	-201.91M
	Financing Cash Flow
-941.42M	-337.30M	-222.07M	363.03M	-31.22M

Healthpeak Properties Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 17.81
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DOC, the sentiment is Negative. The current price of 17.81 is below the 20-day moving average (MA) of 18.26, below the 50-day MA of 19.37, and below the 200-day MA of 20.45, indicating a bearish trend. The MACD of -0.44 indicates Positive momentum. The RSI at 36.03 is Neutral, neither overbought nor oversold. The STOCH value of 18.80 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DOC.

Healthpeak Properties Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
WELL	78 Outperform	$98.56B	162.48	3.52%	1.74%	23.31%	36.07%
OHI	74 Outperform	$10.63B	24.64	10.02%	6.95%	9.90%	56.41%
DOC	69 Neutral	$12.99B	44.81	3.26%	6.78%	23.65%	12.82%
SBRA	63 Neutral	$4.19B	32.82	4.57%	6.81%	7.22%	809.92%
VTR	60 Neutral	$29.44B	336.28	1.36%	2.79%	10.00%	―
Sector *	60 Neutral	$2.78B	11.39	0.16%	8531.54%	5.92%	-14.67%
HR	49 Neutral	$5.58B	―	-10.95%	7.80%	-5.62%	-140.10%

Healthpeak Properties Corporate Events

Healthpeak Properties Approves Employee Stock Purchase Plan

On January 30, 2025, Healthpeak Properties, Inc. adopted an Employee Stock Purchase Plan (ESPP) to allow eligible employees to purchase company stock at a discount, aligning their interests with those of shareholders. The ESPP was approved at the annual meeting on April 24, 2025, where all board nominees were elected, executive compensation was approved, and Deloitte & Touche LLP was ratified as the independent auditor.

Spark’s Take on DOC Stock

According to Spark, TipRanks’ AI Analyst, DOC is a Neutral.

Healthpeak Properties demonstrates solid financial performance with strong revenue growth and operational efficiency. However, declining net profit margins and low ROE highlight areas for improvement. Technical indicators suggest bearish momentum and the high P/E ratio indicates potential overvaluation, though the strong dividend yield provides a cushion. The earnings call reveals sector-specific strengths and challenges, notably in the Lab segment. Overall, the stock reflects a balance of growth potential and inherent risks.

To see Spark’s full report on DOC stock, click here.

Healthpeak Properties Appoints Kelvin O. Moses as CFO

On April 24, 2025, Healthpeak Properties appointed Kelvin O. Moses as Chief Financial Officer, effective immediately, as part of its succession plan. Moses, who joined Healthpeak in 2018 and has held various leadership roles, is expected to guide the company through its next growth phase, leveraging his strategic mindset and healthcare insight. His previous role involved leading the integration of a significant merger, establishing Healthpeak as the largest owner of outpatient medical real estate nationwide.

Spark’s Take on DOC Stock

According to Spark, TipRanks’ AI Analyst, DOC is a Neutral.

Healthpeak Properties exhibits strong financial performance through growth in revenue and operational efficiency, despite declining net profit margins. Positive earnings call highlights strategic successes and growth potential. However, technical indicators show bearish momentum, and the high P/E ratio suggests overvaluation, balancing the positive dividend yield.

To see Spark’s full report on DOC stock, click here.

Healthpeak Properties Reports Q1 2025 Financial Results

Healthpeak Properties reported its financial results for the first quarter of 2025, showing a net income of $0.06 per share and a 7.0% growth in Total Same-Store Portfolio Cash (Adjusted) NOI. The company declared a monthly cash dividend and entered a long-term partnership with Hines for a mixed-use development in Cambridge, Massachusetts. Healthpeak also issued $500 million in senior unsecured notes and repurchased 5.1 million shares, enhancing its liquidity and financial position.

Spark’s Take on DOC Stock

According to Spark, TipRanks’ AI Analyst, DOC is a Neutral.

Healthpeak Properties exhibits strong financial performance through growth in revenue and operational efficiency, despite declining net profit margins. Positive earnings call highlights strategic successes and growth potential. However, technical indicators show bearish momentum, and the high P/E ratio suggests overvaluation, balancing the positive dividend yield.

To see Spark’s full report on DOC stock, click here.

Healthpeak Properties CFO Resigns to Join Healthcare Realty

On April 2, 2025, Peter A. Scott resigned as Chief Financial Officer of Healthpeak Properties, Inc. to become the CEO of Healthcare Realty Trust Incorporated. Healthpeak Properties expressed gratitude for Scott’s eight years of service, during which the company undertook significant portfolio and platform improvements. The company plans to announce an internal successor soon, ensuring a seamless transition and continued organizational impact.

Spark’s Take on DOC Stock

According to Spark, TipRanks’ AI Analyst, (DOC) is a Neutral.

Healthpeak Properties demonstrates solid financial performance with strong revenue growth and cash flow generation. Technical indicators are neutral, and the stock is overvalued but offers a high dividend yield. The recent earnings call was positive, highlighting strategic growth initiatives and successful merger achievements, although there are concerns about increased costs.

To see Spark’s full report on (DOC) stock, click here.

Healthpeak Properties Reports Strong 2024 Financial Results

Healthpeak Properties, Inc. reported its financial results for the fourth quarter and year ended December 31, 2024, on February 3, 2025. The company announced a 1.7% increase in its quarterly common stock cash dividend and highlighted strong leasing performance with over 8 million square feet of lease executions for the year. The company achieved significant merger-related synergies from its merger with Physicians Realty Trust and reported a record year in CCRC performance. Healthpeak also extended the maturity of its $3 billion revolving credit facility to 2029 and secured new sustainability certifications and recognitions.

Healthpeak Properties Announces COO Retirement Plan

Healthpeak Properties announced the retirement of its Chief Operating Officer, Thomas Klaritch, effective March 1, 2025. Klaritch will continue to provide consulting services until the end of 2025, aiding in the transition of his responsibilities, and receive retirement benefits contingent on a Retirement and Release Agreement.